A phase II study of FOLFIRI-3 (double infusion of irinotecan combined with LV5FU) after FOLFOX in advanced colorectal cancer patients

In advanced colorectal cancer previously treated with oxaliplatin, efficacy of irinotecan-based chemotherapy is poor and the best regimen is not defined. We designed FOLFIRI-3 and conducted a phase II study to establish its efficacy and safety in advanced colorectal cancer patients previously treate...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Mabro, M, Artru, P, André, T, Flesch, M, Maindrault-Goebel, F, Landi, B, Lledo, G, Plantade, A, Louvet, C, de Gramont, A
Médium: Artigo
Jazyk:Inglês
Vydáno: Nature Publishing Group 2006
Témata:
Clinical Study
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2361413/
https://ncbi.nlm.nih.gov/pubmed/16622455
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6603095
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky